The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency
Abstract
Non-classic congenital adrenal hyperplasia (NCAH) is a relatively common disorder regardless of ethnicity, but most cases are never diagnosed, especially in males. A baseline 17-hydroxyprogesterone measurement may be used for screening, but 17-hydroxyprogesterone measurement after ACTH stimulation is the gold standard. We advocate a CYP21A2 mutation analysis to verify the diagnosis, for genetic counselling and for better prognostic and treatment guidance. Most patients are diagnosed in adolescence and adult life with hirsutism, acne, a PCOS-like picture and fertility issues. Many men with NCAH never seek medical attention and escape diagnosis. Although treatment is somewhat controversial, an early diagnosis and start of treatment may have positive implications on growth and be relevant for preventing and ameliorating the symptoms and consequences of androgen excess that develop over time, including fertility issues. Long-term treatment with glucocorticoids will improve the androgen symptoms but may result in long-term complications, such as obesity, insulin resistance, hypertension, osteoporosis and fractures. The glucocorticoid doses should be kept low. However, complications seen in NCAH, assumed to be caused by the glucocorticoid treatment, may also be associated with long-term androgen exposure. Oral contraceptive pills are a common treatment option for young females with NCAH. Regular clinical monitoring to improve the clinical outcome is recommended. It is important to acknowledge that glucocorticoid treatment will lead to secondary cortisol insufficiency and the need for stress dosing. Studies focusing on the specific difficulties patients with NCAH face, both those with a late clinical diagnosis and those with a neonatal diagnosis obtained by screening, are warranted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Children with NC CAH can present with signs of increased adrenal androgen production such as premature pubarche, acne, mild hirsutism and menstrual disturbances that can progress over time (427),”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [427]
In the citing paper
“Typical symptoms in affected women are hirsutism, oligo-and amenorrhea, acne, alopecia and sub-or infertility (427).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [427]
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia
Speiser, P., & White, P. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,420
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Escobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr042 · Cited by 494
Vogeser, M., Zachoval, R., Felbinger, T. W., Jacob, K., Radetti, G., Bona, G., Corrias, A., Cappa, M., DeSanctis, V., Lauriola, S., et al. (2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 452
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–159 of 159
Giavoli, C., Iurlaro, E., Morelli, V., Rodari, G., Ronchi, A., Pietrasanta, C., Pugni, L., Tubiolo, D., Properzi, P., Pesenti, A. M., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.602535 · Cited by 3
Chen, S., Wu, L., Ma, X., Guo, L., Zhang, J., Gao, H., & Zhang, T. (2024) · Medicine · doi:10.1097/md.0000000000040297 · Cited by 2
Fedorova, O., & Falhammar, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1693063 · Cited by 2
Self-citationAkbulut, S., Ceylan, Ş. D., Tunçalı, T., & Söğütçü, N. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00408-w · Cited by 2
Sridhar, S., Govindhan, R., Soundian, B., Poomarimuthu, M., Nallan, K., kumar, S. R., Eagappan, S., Natarajan, V., & Jayaraman, S. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_442_21 · Cited by 2
Podgórski, R., Podgórska, D., & Sumińska, M. (2023) · Pediatria Polska · doi:10.5114/polp.2023.133534 · Cited by 1
“However, there are reports indicating that a single morning measurement of 17OHP levels has limited utility in adjusting the glucocorticoid dose [20].”
BackgroundInfluentialConcolino, P., & Paragliola, R. M. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-021-00520-y · Cited by 2
Obermayer-Pietsch, B. M., Ramón, M., Reichmuth, C., Bendig, G., Hutzler, S., Taibon, J., Rank, C. M., & Findeisen, P. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab107 · Cited by 2
Wei, R., Bowers, K., Kroner, G., Payto, D., & Colón-Franco, J. M. (2022) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2022.e00279 · Cited by 2
“Adequately treated patients may have normal or mildly elevated values [19–21], and there is a general consensus to target ASD concentrations within age-adjusted reference intervals [20,21].”
BackgroundSUSILO, E., Zahro, A., SANTOSO, B., & Faradz, S. M. (2022) · International Journal of Islamic Thought · doi:10.24035/ijit.21.2022.224 · Cited by 2
Nordenström, A., & Falhammar, H. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100616 · Cited by 2
Self-citationSpecialty grand challenge in adrenal endocrinology
Falhammar, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1237733 · Cited by 2
Self-citationErtörer, M. E., Anaforoğlu, İ., Yılmaz, N., Akkuş, G., Turgut, S., Ünlühızarcı, K., Selçukbiricik, Ö. S., Merdin, F. A., Karakılıç, E., Koroglu, E. P., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03799-z · Cited by 2
Non-Classic Congenital Adrenal Hyperplasia in Childhood: A Review
Bertolucci, G., Tyutyusheva, N., Sepich, M., Baldinotti, F., Caligo, M. A., Sessa, M. R., Peroni, D. G., & Bertelloni, S. (2023) · Sexes · doi:10.3390/sexes4040030 · Cited by 1
Abseyi, S. N., Karaca, S. E., Şıklar, Z., Şenyazar, G., Çetin, S. K., Demirtaş, Ş., Özsu, E., Aycan, Z., & Berberoğlu, M. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2025-0462 · Cited by 1
Approach to the patient: investigation of postmenopausal androgen excess
Madden-Doyle, L., Bowers, K., Sherlock, M., & O’Reilly, M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag221 · Cited by 1
Lecot‐Connan, T., Bachelot, G., Donadille, B., Sayed, C., Young, J., Fiet, J., Bellanné‐Chantelot, C., Grouthier, V., Christin‐Maître, S., Bachelot, A., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag114 · Cited by 1
Adriaansen, B. P. H., Utari, A., Chandra, E., Falhammar, H., Bonfig, W., Clemente, M., Lenherr‐Taube, N., Markosyan, R. L., de Miranda, M. C., Span, P. N., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag298
Self-citationSevere Hirsutism in Non Classic Congenital Adrenal Hyperplasia: A Case Report and Literature Review
Emini, M., Olldashi, B., & Qovanaj, B. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.3423 · Cited by 1
“It is recommended regular clinical monitoring of glucocorticoid treatment to avoid long-term complications such as insulin resistance, hypertension, obesity, osteoporosis, fractures, and secondary cortisol insufficiency [17].”
BackgroundSimplify your approach to the diagnosis and treatment of PCOS
Barbieri, R. L. (2022) · OBG Management · doi:10.12788/obgm.0247 · Cited by 1
Senarathne, U. D., Abdelmeguid, Y., Raafat, S., Doery, J. C. G., & Falhammar, H. (2023) · Springer eBooks · doi:10.1007/978-3-319-66816-1_1805-1 · Cited by 1
Self-citationVariation in serum adrenal hormones in female 21-hydroxylase deficient patients
Sørensen, D. S. D., Krogh, J., Rasmussen, Å. K., & Andreassen, M. (2022) · Endocrine Connections · doi:10.1530/ec-22-0143 · Cited by 1
Congenital Adrenal Hyperplasia
Ghemigian, A. M., & Dumitru, N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106520 · Cited by 2
Рыкова, О. В. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.15.5.2019.180044
Late-Onset 21-Hydroxylase Deficiency
Igaz, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-62011-0_34
Anastasovska, V., Kočova, M., Zdraveska, N., Stojiljković, M., Skakić, A., Klaassen, K., & Pavlović, S. (2021) · Endocrine · doi:10.1007/s12020-021-02680-7
Onuma, S., Fukuoka, T., Miyoshi, Y., Fukui, M., Satomura, Y., Yasuda, K., Kimura, T., Tachibana, M., Bessho, K., Yamamoto, T., et al. (2021) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.30.143 · Cited by 1
“The clinical phenotype correlates with the less severely mutated allele and, consequently, with residual 21-hydroxylase activity (9).”
BackgroundEstrogens and female developing brain: two sides of the coin
Резніков, А. Г. (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.59.8-12
Fournier, M. E., & Garwood, S. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817962-8.00014-7
Delai, A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-06052022-161625
Winograd, D., Mody, A., Balasubramanyam, A., & Samson, S. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817344-2.00012-5
Adrenal Glands - The Current Stage and New Perspectives of Diseases and Treatment
Păun, D. L., Cianci, P., & Restini, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102209 · Cited by 1
Trends in diagnostics and treatment of congenital adrenal hyperplasia
Milenković, J., Milenković, T., Sedlecki, K., Ilić, P., Kojović, V., Martić, J., Mitrović, K., Todorovic, S., Marjanović, M., Tončev, J., et al. (2023) · Medicinska istrazivanja · doi:10.5937/medi55-41693
Non-classic form of congenital adrenal hyperplasia
Miolski, J., Ješić, M. D., Bojić, V., Kovačević, S., Blagojević, J., Didić, N., & Zdravković, V. (2023) · Medicinska istrazivanja · doi:10.5937/medi56-42715
“Long-term complications of NCCAH include cardiovascular diseases, insulin resistance, obesity, hypertension, diabetes, and psychiatric diseases (1).”
BackgroundInfluentialDynamic Tests in Clinical Endocrinology
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch9
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch3
Physiologie und endokrine Regelkreise
Lotz, L., Lubrich, H., Radosa, J. C., & Findeklee, S. (2023) · Springer eBooks · doi:10.1007/978-3-662-59164-2_2
Romo, K. G., Shu, S., Iqbal, Q. Z., & Uwaifo, G. I. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae018
“Of these, secondary cortisol insufficiency is a particular concern for NCCAH patients with unreliable baseline adrenal function (6).”
BackgroundNoordin, M., Mavinkurve, M., & Nor, N. S. M. (2024) · Malaysian Journal of Paediatrics and Child Health · doi:10.51407/mjpch.v30i1.288
“[4,6].”
Khan, A., Younas, K., & Kevelighan, E. H. (2024) · International Journal of Advanced Multidisciplinary Research and Studies · doi:10.62225/2583049x.2024.4.2.2601
Asperholm, M., Strandqvist, A., Falhammar, H., Frankling, K., Åkerlund, I., Laukka, P., Hirschberg, A. L., Nordenström, A., & Herlitz, A. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4830703
Self-citation21-Hydroxylase deficiency: Clinical and biochemical aspects
Nordenström, A., & Lajić, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00171-0
Self-citationStanchev, P. E., Dimitrova, M., Makakova, D. R., & Tilov, B. G. (2024) · Medicina · doi:10.3390/medicina60122010
“Polysplenia and immunological deficiencies further heighten risks, including infections that affect the adrenal glands and cause adrenal insufficiency [19].”
Unique Case Report: A Rare Association of 21-Hydroxylase Deficiency with Triple X Karyotype
Azulay, R. S. D. S., Facundo, A. N., Sousa, S. S. E., Nascimento, G. C., Magalhães, M., Neto, C. P. D. O., de Abreu, J. D. M. F., Lago, D. C. F., Damianse, S. D. S. P., Carvalho, V. C., et al. (2025) · Genes · doi:10.3390/genes16030354
Transition bei komplexen endokrinologischen und diabetologischen Erkrankungen
Kiewert, C., Führer, D., & Unger, N. (2025) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-025-02213-w
Transition bei komplexen endokrinologischen und diabetologischen Erkrankungen
Kiewert, C., Führer, D., & Unger, N. (2025) · Die Innere Medizin · doi:10.1007/s00108-025-01927-z
Huang, Y., Jiang, H., Zhu, X., Mao, A., Cui, D., Zhao, Y., Wang, Y., Long, X., & Qiao, J. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01824-x · Cited by 1
“In contrast, NCCAH generally presents with mild phenotypes and may be identified in female patients with hirsutism, acne, menstrual disorders, or impaired fertility [4, 5].”
Young, J. (2025) · EMC - Gynécologie · doi:10.1016/s0246-1064(24)47746-3
Qiu, R., Yang, T., Shang, C., Zhu, W., & Zheng, F. (2026) · Diagnostics · doi:10.3390/diagnostics16020202
“A 17-OHP level greater than 30 nmol/L (10 ng/mL) after adrenocorticotropic hormone (ACTH) stimulation strongly suggests 21OHD, although most patients with NC-21OHD exhibit stimulated levels between 30 and 300 nmol/L [7].”
Munarin, J., Tuli, G., Pavanello, E., & SANCTIS, L. D. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15072631
FERREIRA, B., Robin, G., Pigny, P., Bachelot, A., RIBIERE, L., & Catteau-Jonard, S. (2026) · Gynecological Endocrinology · doi:10.1080/09513590.2026.2659979
Neonatal Screening for CAH in Sweden—Results of Implementing Second-Tier Testing
Engström, K., Zetterström, R. H., Wedell, A., & Nordenström, A. (2026) · International Journal of Neonatal Screening · doi:10.3390/ijns12020029 · Cited by 1
Self-citationYoung, J. (2026) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(26)51703-x
Verde, V., Wörther, H., Kühle, A., Grunwald, P., Tschaidse, L., Chojnacki, M., Ilmberger, S., Berente, S., Reisch, N., & Krämer, U. M. (2026) · Hormones and Behavior · doi:10.1016/j.yhbeh.2026.105953 · Cited by 1
Polito, N. D., Gambarota, F., Hampson, E., & Herlitz, A. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106877
Crinecerfont: emerging role in the management of congenital adrenal hyperplasia
Fedorova, O., & Falhammar, H. (2026) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2026.2713482
“NC-CAH, meanwhile, may present later in life with signs of androgen excess such as hirsutism, acne, or menstrual irregularities in females, while males are generally asymptomatic [5,6].”
Self-citationHyperandrogénies etsyndrome desovaires polykystiques chezl'adolescente
Robin, G., & Catteau-Jonard, S. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78647-1.00019-7
Xia, Y., Cui, D., Li, D., Chen, L., Chen, X., Wu, S., Mao, A., & Kong, X. (2026) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2026.08.004
Diagnóstico y manejo de la hiperplasia suprarrenal congénita: revisión sistemática
Sanchez-Zambrano, J., Zamora-Trejo, I. B., & Castellano-Castellano, F. G. (2026) · Cuaderno de odontología. Revista científica. · doi:10.62574/sodygynv
Metadata
- Authors
- Nordenström, A., & Falhammar, H.
- Affiliations
- Karolinska University Hospital (SE)
- Corresponding author
- Nordenström, Anna
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03
- Volume
- 180
- Issue
- 3
- Pages
- R127-R145
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2904713638
- Cited by
- 158
- References
- 166
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 22 · 2023: 30 · 2022: 27 · 2021: 25 · 2020: 20 · 2019: 9
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- non-classical congenital adrenal hyperplasia, 21-hydroxylase deficiency, 17-hydroxyprogesterone, ACTH stimulation test, hirsutism, hyperandrogenism, glucocorticoid therapy, glucocorticoid adverse effects, oral contraceptives, fertility, genetic counseling, screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
